Qlaris Bio is a Biotech company based in Dedham, Massachusetts. It has raised $49M in total funding. Latest round: Series B.
Qlaris Bio funding overview
Qlaris Bio is a Biotech company based in Dedham, Massachusetts. Qlaris Bio has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2024. The round record for Qlaris Bio runs through 2024; nothing later has been disclosed. Investors on record include Canaan, New Leaf Venture Partners, abrdn Inc., Mayo Clinic Ventures, Correlation Ventures. 5 distinct backers are named across the disclosed rounds.
Qlaris Bio at a glance
Total raised
$49M
Latest round
Series B
Latest round date
April 2024
Industry
Biotech
Headquarters
Dedham, Massachusetts
Notable investors
Canaan, New Leaf Venture Partners, abrdn Inc., Mayo Clinic Ventures, Correlation Ventures
Frequently asked about Qlaris Bio funding
How much has Qlaris Bio raised?
Qlaris Bio has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Qlaris Bio?
Canaan, New Leaf Venture Partners, abrdn Inc., Mayo Clinic Ventures, Correlation Ventures are named among the investors backing Qlaris Bio.
What was the latest Qlaris Bio funding round?
The most recent disclosed round is a Series B, announced in April 2024.
Where is Qlaris Bio based?
Qlaris Bio is based in Dedham, Massachusetts.
What sector does Qlaris Bio operate in?
Qlaris Bio is tracked under Biotech from Dedham, Massachusetts, with $49M in disclosed funding.
When did Qlaris Bio last raise?
The last disclosed Qlaris Bio round closed in April 2024 at Series B.
Round data for Qlaris Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Dedham and backer lists below.
